Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients
- 1 December 2016
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 255, 200-209
Abstract
No abstract availableKeywords
Funding Information
- Merck
This publication has 43 references indexed in Scilit:
- Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapyVascular Health and Risk Management, 2013
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart DiseaseJACC, 2012
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Gender differences in the implementation of cardiovascular prevention measures after an acute coronary eventHeart, 2010
- Predictors of Nonadherence to Statins: A Systematic Review and Meta-AnalysisAnnals of Pharmacotherapy, 2010
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countriesThe Lancet, 2009
- Mixed Dyslipidemia Among Patients Using Lipid-Lowering Therapy in French General Practice: An Observational StudyClinical Therapeutics, 2007
- Effects of Statins on 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Beyond Low-Density Lipoprotein CholesterolThe American Journal of Cardiology, 2005